Latest news
Nov 15, 2022
BD to Present at Evercore ISI 5th Annual HealthCONx Conference

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present virtually at the Evercore ISI 5th Annual HealthCONx Conference on...

Nov 10, 2022
BD Reports Fourth Quarter and Full Year Fiscal 2022 Financial Results

Execution of BD 2025 Strategy Driving Consistent Durable Growth Q4 revenue from continuing operations of $4.8 billion decreased 1.8% as reported and increased 2.3% on a currency-neutral basis Q4...

All news ›

Blog
Nov 21, 2022
BD Infectious Disease Insights: The COVID-19 Pandemic’s Impact on Antimicrobial Resistance (Part 2)

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs In August, we provided data showing that the COVID-19 pandemic has undone...

Nov 17, 2022
BD Infectious Disease Insights: Weekly COVID-19, Flu and RSV Snapshot (November 17)

By Kalvin Yu, MD, FIDSA, Vice President of U.S. Medical Affairs and Vikas Gupta, Pharm.D., Director of Medical Affairs This is our third weekly snapshot of viral infections across the U.S. At the...

More »

News and media

Twitter
YouTube
Loading...
Facebook